You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. ANYTIME, ANYPLACE LEARNING FOR CRITICAL CARE

    SBC: ACADEMIC EDGE, INC.            Topic: N/A

    completion, the entire course will provide a professional certificate with continuing nursing education contact hours or can be transferred as academic credit in an undergraduate-nursing program. The model for the OCPP to be developed in this project has three components: didactic core content, clinical practicum, and a Virtual Center of Best Practices. The core ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  2. NON-NATURAL AMINO ACIDS IN PEPTIDE DRUG DEVELOPMENT

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    Argolyn Bioscience Inc. is an early stage biotechnology company that creates novel peptide drugs and diagnostics with greatly improved intrinsic pharmaceutical properties through substitution of non-natural amino acid analogues for arginine (Arg) or lysine (Lys). In proof-of concept studies thus far, application of the Argolyn technology to peptides of therapeutic interest has resulted in dramatic ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  3. NOVEL NEUROTENSIN ANALOGS AS ANTISCHIZOPRENICS

    SBC: ARGOLYN BIOSCIENCE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The brain peptide neurotensin (NT) and its active derivative NT [8-13] function as endogenous neuroleptics. Stable NT derivatives that cross the blood brain barrier therefore have significant potential for development as a new class of non-dopamineric antipsychotics expected not to display the adverse side effects associated with the dopaminergics. The best lit ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  4. A HOMOGENEOUS TRANSMIT COIL FOR HIGH FIELD HUMAN NMR

    SBC: BIOENGINEERING, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II STTR project, the investigators plan to extend their successful Phase I feasibility demonstration to the development and manufacture of an RF body coil plus phased array receive system for use in high field clinical and research MRI systems. In Phase I, the feasibility of a large homogeneous transmit coil based on the TEM design was proven, pub ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  5. A HOMOGENEOUS TRANSMIT COIL FOR HIGH FIELD HUMAN NMR

    SBC: BIOENGINEERING, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In this Phase II STTR project, the investigators plan to extend their successful Phase I feasibility demonstration to the development and manufacture of an RF body coil plus phased array receive system for use in high field clinical and research MRI systems. In Phase I, the feasibility of a large homogeneous transmit coil based on the TEM design was proven, pub ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  6. PRECISE 3D QCT TO MONITOR OSTEOPOROSIS THERAPY

    SBC: IMAGE ANALYSIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):The growing number of women receiving drug treatment for osteoporosis underscores the need for sensitive methods to monitor therapy. Because it permits selective assessment of the trabecular and cortical bone, which may respond differently to disease and therapy, quantitative computed tomography (QCT) is well-suited to this purpose. However, the ability of QCT t ...

    STTR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  7. PRECISE 3D QCT TO MONITOR OSTEOPOROSIS THERAPY

    SBC: IMAGE ANALYSIS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant):The growing number of women receiving drug treatment for osteoporosis underscores the need for sensitive methods to monitor therapy. Because it permits selective assessment of the trabecular and cortical bone, which may respond differently to disease and therapy, quantitative computed tomography (QCT) is well-suited to this purpose. However, the ability of QCT t ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. ENHANCED THERMAL TRANSFER DEVICE FOR BIOPRESERVATION

    SBC: ORGAN RECOVERY SYSTEMS, INC.            Topic: N/A

    Effective methods of preserving cells and tissues are essential for the established and emerging companies using cryopreservation as part of their production processes. Conventional freezing and thawing devices have low heat transfer efficiencies that cause non-uniform thermal processing in biological materials resulting in products with low and inconsistent cell viability. The development of an a ...

    STTR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. Pocketable Language Translation System for use in Noisy Environments

    SBC: SPEECHGEAR, INC.            Topic: N/A

    Mission Statement: "To develop and deploy a Pocketable Language Translation System (PLTS) that identifies and translates keywords as they are spoken even though significant background noise and/or degradation of the audio signal may be present. Thesystem shall support bi-directional identification and translation of multiple languages. Conversations of interest shall be automatically recorded, ...

    STTR Phase I 2002 Department of DefenseNavy
  10. Low Pressure Source for Mass-Selective, Diffusion Assisted Epitaxy

    SBC: SVT ASSOCIATES INC            Topic: N/A

    Dramatic differences in the diffusivities of the constituents of novel thin film materials and structures limit material perfection under far from equilibrium growth conditions. We will develop a new light-mass ion source, compatible with the low pressurerequirements of molecular beam epitaxy (MBE), to provide selective enhancement of the motion of surface atoms. Helium or hydrogen ions incident ...

    STTR Phase I 2002 Department of DefenseAir Force
US Flag An Official Website of the United States Government